Roundup Weedkiller Cancer Claims Reached a Legal Milestone on Friday
Roundup weedkiller cancer claims reached a legal milestone on Friday when a Missouri judge approved a $7.25bn Bayer settlement to resolve lawsuits from sick users.
St. Louis Circuit Judge Timothy Boyer found the nationwide agreement “fair, reasonable, and adequate”, according to BBC News. The accord covers individuals currently suffering from non-Hodgkin lymphoma alongside anyone who contracts the illness in future years.
Individual payouts span from $10,000 to $165,000. Final amounts depend on exposure frequency, diagnosis timing, and illness severity, BBC News reported. Bayer will fund the liability through annual payments stretching up to 21 years.
Some opposing attorneys argued the proposed compensation was inadequate. Judge Boyer countered that delaying payouts would force terminal patients to wait an indeterminate number of years for relief, as reported by the Guardian.

“The court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation,” said Bill Anderson, Bayer’s chief executive officer, in a statement cited by the Guardian.
Germany-based Bayer acquired the weedkiller when it bought Monsanto for $63bn in 2018. Since that transaction, the agrochemical maker’s share price dropped 46% amid ongoing legal battles, according to the Guardian. The company previously paid roughly $10bn to resolve earlier waves of litigation, while maintaining that its products do not cause cancer.
The approval follows a June Supreme Court ruling that favored the corporate defendant in a separate case. That 7-2 decision established that federal pesticide regulations bar state-level failure-to-warn claims because federal rules do not mandate cancer warning labels.
| Litigation Milestone | Financial Scale | Status |
|---|---|---|
| Monsanto Acquisition | $63bn (2018) | Completed |
| Prior Settlement Fund | $10.9bn (2020) | Executed |
| Current Court Approval | $7.25bn (2026) | Approved |
Christopher Seeger, a lawyer representing numerous plaintiffs, said that the high court’s precedent narrowed victims’ abilities to pursue court claims. “We look forward to getting this relief into the hands of all Roundup victims as quickly as possible,” he said in a statement reported by the Guardian.
Approximately 200 federal lawsuits remain active outside the scope of the approved settlement. Bayer said that about 200 of those remaining cases retain strong defenses following the supreme court precedent, according to the Guardian.
Roundup was developed by Monsanto in the 1970s with glyphosate as its active ingredient. The World Health Organization’s International Agency for Research on Cancer classified glyphosate as a probable human carcinogen in 2015, while Bayer and the U.S. Environmental Protection Agency have disputed those findings.
Bayer, the German pharmaceutical and life-sciences giant that acquired Monsanto in 2018, traces its roots to 1863 when Friedrich Bayer and Johann Friedrich Weskott founded a dyestuffs factory in Barmen. The company became a global household name in 1899 when it launched Aspirin, the first synthetic drug to be mass-marketed, which remains on the World Health Organization’s List of Essential Medicines.
In 1925 Bayer merged into IG Farben, the industrial conglomerate later dismantled by the Allies for its role in the Nazi war effort, including the production of Zyklon B. Reconstituted in 1951, Bayer helped drive West Germany’s post-war economic miracle before the Monsanto takeover, now widely regarded as one of the most disastrous mergers in corporate history, erased nearly half its market value.
Lawyers for some of the Roundup victims who objected to the settlement did not immediately respond to requests for comment.
Keep reading
- Switzerland and Ukraine Exchange Digital Governance Strategies for Crisis Resilience and Multi-Level Coordination
- Bitcoin Falls to $55,533, Lowest Since September 2024, E24 Reports
- Pope Leo XIV Cleared for South America Tour After Lung Cancer Surgery (newsdirectory3.com)
- Jordan Stolz Wins 500m in Obihiro, Takes 1,500m Silver as Ning Zhongyan Claims Gold (newsy-today.com)